Yatsen Announces First Quarter 2026 Financial Results

Revenue is up, but losses are widening and cash is shrinking—caution is warranted.

What the company is saying

Yatsen Holding Limited positions itself as a leading China-based beauty group experiencing robust top-line growth, especially in its skincare brands. The company highlights a 22.5% year-over-year increase in total net revenues to RMB1.02 billion and a 58.5% surge in skincare brand revenues, framing these as evidence of successful brand expansion and market traction. Management emphasizes improved gross margin (up to 80.2% from 79.1%) and the rapid growth of its premium and clinical skincare brands, Galénic, DR.WU, and Eve Lom, which collectively grew revenues by 61.4%. The announcement foregrounds these growth metrics and the completion of a US$120 million private placement with participation from Trustar Capital, Hillhouse, and CEO Jinfeng Huang, aiming to signal institutional confidence and financial flexibility. However, the company downplays or buries the sharp increase in net loss (from RMB5.6 million to RMB61.9 million) and the reversal from non-GAAP net income to a significant non-GAAP net loss. The tone is measured and neutral, with management projecting confidence in their strategy and a commitment to long-term profitability optimization, but without overhyped language. Notably, CEO Jinfeng Huang is both a participant in the capital raise and the public face of the company, which may reassure some investors but does not substitute for external validation. The narrative fits a classic growth-company playbook: focus on revenue momentum and brand-building, while asking investors to look past current losses in anticipation of future margin improvement. Compared to prior communications (where available), there is no evidence of a dramatic shift in messaging, but the emphasis on institutional participation in the capital raise is a new focal point.

What the data suggests

The disclosed numbers show that while Yatsen's revenues are growing strongly, profitability is deteriorating. Total net revenues for Q1 2026 rose 22.5% to RMB1.02 billion, with skincare brands accounting for 56.2% of the total, up from 43.5% a year earlier. Gross margin improved modestly to 80.2%, but this was more than offset by a 32.5% jump in total operating expenses to RMB918.1 million, driven by higher selling, marketing, and R&D costs. Net loss widened sharply to RMB61.9 million from RMB5.6 million, and non-GAAP net income swung to a loss of RMB57.3 million from a profit of RMB7.1 million. Cash, restricted cash, and short-term investments fell to RMB934.2 million from RMB1.05 billion at year-end 2025, and net cash used in operating activities was RMB90.0 million, compared to positive cash generation a year earlier. The company’s guidance for Q2 2026 projects further revenue growth (10-20% year-over-year), but this is a forward-looking statement and not yet realized. The financial disclosures are detailed for headline metrics, but lack operational granularity (e.g., unit sales, customer counts, or segment profitability), making it difficult to assess the sustainability of growth or the path to profitability. An independent analyst would conclude that while the company is successfully growing its top line and expanding its skincare brands, the cost structure is outpacing revenue gains, and the business is burning cash at an accelerating rate.

Analysis

The announcement is largely factual, with the majority of claims supported by realised, audited financial results for the first quarter of 2026. The only forward-looking claim is the revenue guidance for the second quarter of 2026, which is a standard practice in earnings releases and is clearly identified as management's expectation rather than a guaranteed outcome. There is no evidence of exaggerated or promotional language; the tone is measured and focuses on both positive (revenue and gross margin growth) and negative (widening net loss, increased expenses) developments. The capital raise via convertible notes is disclosed as completed, not merely planned, and there is no indication of large, speculative capital outlays with uncertain returns. The gap between narrative and evidence is minimal, with the data supporting the company's main claims.

Risk flags

• ●Profitability risk: Despite strong revenue growth, net loss widened from RMB5.6 million to RMB61.9 million year-over-year, and non-GAAP net income turned into a significant loss. This trend suggests that the company’s growth is not translating into bottom-line improvement, which is a major concern for investors seeking sustainable returns.
• ●Cash burn risk: Cash, restricted cash, and short-term investments declined from RMB1.05 billion at year-end 2025 to RMB934.2 million at March 31, 2026, and net cash used in operating activities was RMB90.0 million for the quarter. Persistent cash burn at this rate could force further dilutive capital raises or debt issuance if profitability is not achieved soon.
• ●Expense escalation risk: Operating expenses increased by 32.5% year-over-year, outpacing revenue growth. Selling and marketing expenses alone rose to RMB737.2 million, suggesting that customer acquisition and brand-building are becoming more expensive and may not be sustainable without margin improvement.
• ●Forward-looking claims risk: The company’s guidance for Q2 2026 and statements about future profitability are not yet realized and should be treated with skepticism until actual results are reported. The majority of the positive narrative is based on projections rather than achieved outcomes.
• ●Capital intensity risk: The company completed a US$120 million private placement of convertible notes and warrants, signaling a need for external capital to fund operations and growth. While this provides a temporary liquidity boost, it also introduces dilution risk and potential future interest or conversion costs.
• ●Disclosure risk: While headline financials are detailed, the lack of operational metrics (such as unit sales, customer retention, or segment profitability) limits an investor’s ability to assess the underlying health and scalability of the business model.
• ●Execution risk: Management’s stated focus on cost optimization and margin improvement is not yet reflected in the numbers. If the company fails to deliver on these promises in the next few quarters, investor confidence and share price could suffer.
• ●Geographic concentration risk: The company is based in China and operates in a highly competitive and rapidly evolving consumer market, which can introduce regulatory, market, and currency risks that may not be fully captured in the financials.

Bottom line

For investors, this announcement means that Yatsen is delivering strong revenue growth, especially in its skincare brands, but at the cost of sharply widening losses and accelerating cash burn. The company’s narrative of brand expansion and future profitability is credible only to the extent that it can quickly translate top-line gains into sustainable margins and positive cash flow. The participation of institutional investors like Trustar Capital and Hillhouse in the recent US$120 million private placement is a positive signal of external confidence, but it does not guarantee future funding or operational success. To change this assessment, the company would need to show clear evidence of expense control, a path to profitability, and improved cash generation in subsequent quarters. Key metrics to watch in the next reporting period include net loss, operating cash flow, and whether revenue growth continues to outpace expense growth. Investors should monitor the company closely rather than act on this signal, as the risks of ongoing losses and cash depletion are significant. The most important takeaway is that while Yatsen’s growth story is real, the financial fundamentals are deteriorating, and management must deliver on cost control and profitability soon to justify continued investment.

Announcement summary

Yatsen Holding Limited (NYSE: YSG), a leading China-based beauty group, announced its unaudited financial results for the quarter ended March 31, 2026. Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million), driven primarily by a 58.5% year-over-year increase in net revenues from Skincare Brands. Gross margin improved to 80.2% from 79.1% in the prior year period, while net loss widened to RMB61.9 million (US$9.0 million) compared to RMB5.6 million a year earlier. The company completed the first closing of a private placement of convertible notes and warrants totaling approximately US$120 million on May 21, 2026. As of March 31, 2026, Yatsen had cash, restricted cash, and short-term investments of RMB934.2 million (US$135.4 million). For the second quarter of 2026, the company expects total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These results and forecasts reflect Yatsen's ongoing focus on expanding its core brands and optimizing profitability.

Disagree with this article?